It is my pleasure and honor to host the “4th International Bahçeşehir University (BAU) Drug Design Congress” at the BAU, School of Medicine, in Istanbul. It will bring together renowned industrial and academic experts to further discuss the recent developments and advances in the drug design field.
The main theme of the BAU-Drug Design 2016 Congress will be “Recent Developments in Structure- and Ligand-based Drug Design Methodologies,” which will cover a wide range of critically important topics such as:
Novel Applications in Cancer Therapy
Synthesis of small organic molecules
From Bench to Clinical Applications
Potential Drug Carrier Systems
Design and applications of Bio-Probes in diagnosis, cell recognition and monitoring
Gene Network Analysis
Experimental techniques for Drug-Protein interactions
NMR-Supported Structural Biology of Drug Targets
Molecular Docking and Molecular Dynamics (MD) Simulations
De Novo Drug Design
Analysis of Protein/Protein and Drug/Protein Interactions
High Throughput Screening Methods
Protein Flexibility and Dynamics
High Performance Computing
Virtual Screening of Large number of small molecules
The congress aims to serve as a platform for interaction among leading experimental and computational scientists from academia and industry to discuss the latest developments in methodology, application and approaches in the drug design field and to accelerate scientific discovery as well as reflect the key goals of the strategic priorities of the university: Integration, inter-disciplinary research on basic health sciences.
I look forward to welcoming the participants to this exciting congress in the magical city of Istanbul in October 2016.
Assoc. Prof. Dr. Serdar DURDAGI
Chairman of the Congress